Finanskalender 2024
30 nov. 2023 05h05 HE
|
ORPHAZYME A/S
Vedhæftet er oversigt over selskabets finanskalender for 2024. Onsdag den 20. marts 2024Årsrapport 2023Torsdag den 11. april 2024Ordinær generalforsamlingTirsdag den 14. maj 2024Periodemeddelelse for...
Minutes of the Extraordinary General Meeting of Orphazyme A/S
30 nov. 2023 05h01 HE
|
ORPHAZYME A/S
An extraordinary general meeting was held in Orphazyme A/S, company reg.no. 32266355 (the “Company”) on Thursday, 30 November at 10:00 (AM) at the Company’s address at Lyskjær 8A, 2730 Herlev Agenda:...
Notice of Extraordinary General Meeting in Orphazyme A/S
08 nov. 2023 12h28 HE
|
ORPHAZYME A/S
The board of directors hereby convenes for an extraordinary general meeting in Orphazyme A/S at the company’s address at Lyskjær 8A, 2730 Herlev on Thursday 30 November 2023 at 10.00 AM (CET). ...
Business update October 2023
08 nov. 2023 12h23 HE
|
ORPHAZYME A/S
Unless otherwise stated, comments in this announcement refer to performance from continuing operations from 1 January – 31 October 2023. Net loss for the 10 months ended October 2023 totaled DKK 29...
Process for reverse share split at a consolidation ratio of 1.000:1
02 nov. 2023 05h42 HE
|
ORPHAZYME A/S
At the company’s extraordinary general assembly November 2nd 2023 it was decided to implement a reverse share split at a consolidation ratio of 1.000:1, see company announcement 18/2023. The reverse...
Decisions of extraordinary general assembly
02 nov. 2023 05h35 HE
|
ORPHAZYME A/S
The company convened its extraordinary general assembly today November 2nd 2023 10.00 AM (CEST) at its office address, Lyskær 8A, 2730 Herlev, see company announcement 17/2023 for the full...
Notice convening the Extraordinary General Meeting of Orphazyme A/S
11 oct. 2023 04h58 HE
|
ORPHAZYME A/S
The Board of Directors hereby convenes an Extraordinary General Meeting to be held at the Company’s address at Lyskjær 8A, 2730 Herlev on Thursday November 2nd 2023 at 10:00 AM (CEST). Agenda: ...
Notice of proposal to Consolidate Shares in Orphazyme A/S
11 oct. 2023 04h53 HE
|
ORPHAZYME A/S
As described in Company Announcements 12/2023, the strategy for Orphazyme is to optimize the cost structure of the company, while the search for a new activity is ongoing. To reduce the running...
Share-based incentive program
06 oct. 2023 02h37 HE
|
ORPHAZYME A/S
In accordance with the authorization from the General Meeting on May 17’th 2023 and Company announcement 8/2023 the Board of Directors in Orphazyme A/S has today introduced an incentive program for...
Preliminary court approval on US Security class action case
06 oct. 2023 01h55 HE
|
ORPHAZYME A/S
As communicated several times, latest in Company announcement 12/2023, Orphazyme is part of a US class action lawsuit. The court has granted preliminary approval of the proposed settlement and...